Mechanistic description
Identification of a TREM2-independent disease-associated microglial (DAM) trajectory in late-stage AD. Single-cell analysis reveals microglial subclusters expressing elevated APOE, CSF1R, and CX3CR1 without TREM2 activation markers, suggesting an alternative activation pathway driving neuroinflammation through C3 upregulation.
Mechanism / pathway
- CSF1R
- neurodegeneration
Evidence for (3)
DAM progression documented in AD cortex
TREM2-dependent DAM identified in mouse models
APOE4 drives microglial inflammation
Evidence against (2)
TREM2-dependent and independent DAM converge on lipid metabolism signatures
APOEε4 microglial inflammation requires TREM2 signaling
Evidence matrix
Supporting
- DAM progression documented in AD cortex PMID:30617256
- TREM2-dependent DAM identified in mouse models PMID:28602351
- APOE4 drives microglial inflammation PMID:32376951
Contradicting
- TREM2-dependent and independent DAM converge on lipid metabolism signatures PMID:unavailable
- APOEε4 microglial inflammation requires TREM2 signaling PMID:unavailable
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). TREM2-Independent Microglial Activation via CSF1R. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-59dcb68e7d
@misc{scidex_hypothesis_h59dcb68,
title = {TREM2-Independent Microglial Activation via CSF1R},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-59dcb68e7d},
note = {SciDEX artifact hypothesis:h-59dcb68e7d}
}